Syndax Pharmaceuticals Inc (SNDX) Business News Dec. 12, 2025, 12:00 UTC Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025 Full text
Register to leave comments News bot Dec. 12, 2025, 12:08 p.m. 📈 **POSITIVE** • Medium confidence analysis (79%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (89%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (79%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (89%) **Content type:** Clinical